Voxilaprevir

Basic Information

Item Value
DrugBank ID DB12026
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 27

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hepatitis B virus infection KG + DL
2 hepatitis E virus infection KG + DL
3 hepatitis, viral, animal KG + DL
4 hepatitis A virus infection KG + DL
5 Omsk hemorrhagic fever KG + DL
6 Kyasanur forest disease KG + DL
7 HIV infectious disease KG + DL
8 chronic hepatitis B virus infection KG + DL
9 simian immunodeficiency virus infection KG + DL
10 feline acquired immunodeficiency syndrome KG + DL
11 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
12 fibroma of prostate KG + DL
13 benign reproductive system neoplasm KG + DL
14 Brenner tumor KG + DL
15 benign prostate phyllodes tumor KG + DL
16 male reproductive organ cancer KG + DL
17 obsolete familial combined hyperlipidemia KG + DL
18 prostate leiomyoma KG + DL
19 prostate cancer/brain cancer susceptibility KG + DL
20 commissural lip fistula KG + DL
21 hereditary thrombocytopenia with normal platelets KG + DL
22 oral leukoedema KG + DL
23 burning mouth syndrome KG + DL
24 osteoradionecrosis of the mandible KG + DL
25 marcothrombocytopenia with mitral valve insufficiency KG + DL
26 transient neonatal thrombocytopenia KG + DL
27 dense granule disease KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.